# Chrysin Bioavailability and Safety

> **NCT07066839** · NA · COMPLETED · sponsor: **Isura** · enrollment: 18 (actual)

## Conditions studied

- Bioavailability and Pharmacokinetics
- Safety After Oral Intake

## Interventions

- **DIETARY_SUPPLEMENT:** LipoMicel Chrysin
- **DIETARY_SUPPLEMENT:** Non-Micellar Chrysin
- **DIETARY_SUPPLEMENT:** Standard/Unformulated Chrysin

## Key facts

- **NCT ID:** NCT07066839
- **Lead sponsor:** Isura
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-05
- **Primary completion:** 2025-02-21
- **Final completion:** 2025-04-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07066839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07066839, "Chrysin Bioavailability and Safety". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT07066839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*